Lochner Daniel 4

What Happened

• Daniel Lochner, Chief Financial Officer of Tectonic Therapeutic (TECX), bought 6,000 shares in an open-market purchase on 2026-02-10. The reported weighted-average price was $21.61 per share, for a total transaction value of about $129,660. This is a purchase (acquisition) rather than a sale.

Key Details

• Transaction date: 2026-02-10; Filing date: 2026-02-11 (timely filing).
• Transaction type/code: Open market purchase (P).
• Shares purchased: 6,000; weighted-average price: $21.61; total value: ~$129,660.
• Footnote: The $21.61 is a weighted-average — trades occurred at prices ranging from $21.24 to $21.82. The reporting person will provide a breakdown of shares per price on request.
• Shares owned after transaction: Not reported in this filing.
• No 10b5-1 plan, option exercise, gift, or tax-withholding noted in this filing.

Context

• Insider purchases can be interpreted as a personal investment signal, but do not prove future company performance; retail investors should consider this alongside broader fundamental and market information. This filing reports a straightforward open-market buy with no derivatives or sales involved.